

HY-131088 · 50 mg
MedChemExpress · Cat: HY-131088
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/n3-peg8-phe-lys-pabc-gefitinib.html
Description
N3-PEG8-Phe-Lys-PABC-Gefitinib is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-tumor agent, Gefitinib orally active EGFR tyrosine kinase inhibitor , linked via the cleavable linker N3-PEG8-Phe-Lys-PABC. N3-PEG8-Phe-Lys-PABC-Gefitinib is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction CuAAc with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition SPAAC reactions with molecules containing DBCO or BCN groups.







